Amyloidogenicity and Clinical Phenotype Associated with Five Novel Mutations in Apolipoprotein A-IROWCZENIO, Dorota; DOGAN, Ahmet; PINNEY, Jenny H et al.The American journal of pathology. 2011, Vol 179, Num 4, pp 1978-1987, issn 0002-9440, 10 p.Article

Effects of a major gene for apolipoprotein A-I concentration are thyroid hormone dependent in Mexican AmericansBLANGERO, J; WILLIAMS-BLANGERO, S; MAHANEY, M. C et al.Arteriosclerosis, thrombosis, and vascular biology. 1996, Vol 16, Num 9, pp 1177-1183, issn 1079-5642Article

Precipitation procedures used to isolate high density lipoprotein with particular reference to effects on apo A-I-only particles and lipoprotein(a)VALLANCE, D. T; BYRNE, D. J; WINDER, A. F et al.Clinica chimica acta. 1994, Vol 229, Num 1-2, pp 77-85, issn 0009-8981Article

Enhanced Delivery of Adenovirus, Using Proteoliposomes Containing Wildtype or V156K Apolipoprotein A-I and DimyristoylphosphatidylcholinePARK, Ki-Hoon; YUN, Chae-Ok; KWON, Oh-Joon et al.Human gene therapy. 2010, Vol 21, Num 5, pp 579-587, issn 1043-0342, 9 p.Article

PLACE DES DOSAGES DES APOLIPOPROTEINES A1 ET B DANS LE BILAN LIPIDIQUE: RAPPORT D'EVALUATION TECHNOLOGIQUEAngéiologie (Paris). 2009, Vol 61, Num 2, pp 17-29, issn 0003-3049, 13 p.Article

A single amino acid deletion in the carboxy terminal of apolipoprotein A-I impairs lipid binding and cellular interactionWEI HUANG; SASAKI, J; MATSUNAGA, A et al.Arteriosclerosis, thrombosis, and vascular biology. 2000, Vol 20, Num 1, pp 210-216, issn 1079-5642Article

Low Rate of Production of Apolipoproteins B100 and AI in 2 Patients With Anderson Disease (Chylomicron Retention Disease)OUGUERRAM, Khadija; ZAIR, Yassine; SAMSON-BOUMA, Marie Elisabeth et al.Arteriosclerosis, thrombosis, and vascular biology. 2012, Vol 32, Num 6, pp 1520-1525, issn 1079-5642, 6 p.Article

Elevation of Plasma High-Density Lipoproteins Inhibits Development of Experimental Abdominal Aortic AneurysmsTORSNEY, Evelyn; PIRIANOV, Grisha; COCKERILL, Gillian W et al.Arteriosclerosis, thrombosis, and vascular biology. 2012, Vol 32, Num 11, pp 2678-2686, issn 1079-5642, 9 p.Article

Plasma apolipoprotein E concentration is an important determinant of phospholipid transfer protein activity in type 2 diabetes mellitusTAM, K. C. B; SHIU, S. W. M; WONG, Y et al.Diabetes/metabolism research and reviews (Print). 2006, Vol 22, Num 4, pp 307-312, issn 1520-7552, 6 p.Article

Minimal lipidation of pre-β HDL by ABCA1 results in reduced ability to interact with ABCA1MULYA, Anny; LEE, Ji-Young; GEBRE, Abraham K et al.Arteriosclerosis, thrombosis, and vascular biology. 2007, Vol 27, Num 8, pp 1828-1836, issn 1079-5642, 9 p.Article

A novel polymorphism (1121 C/T) in intron 3 of the human apolipoprotein A-I geneMOTTI, C; BETTE, C; BIAGIOTTI, L et al.Clinical genetics. 1997, Vol 51, Num 2, pp 127-128, issn 0009-9163Article

Genetic relationship between equine apolipoproteins A4 and A1KAKOI, H; GAWAHARA, H.Animal genetics (Print). 1997, Vol 28, Num 4, pp 306-307, issn 0268-9146Article

Simple one-step procedure for the separation of apolipoproteins A1 and A2 by high-performance liquid chromatographyXIONG, Z.Journal of chromatography. B, Biomedical sciences and applications. 1997, Vol 702, Num 1-2, pp 216-220, issn 1387-2273Article

Preβ₁-high-density lipoprotein increases in coronary artery diseaseMIIDA, T; NAKAMURA, Y; INANO, K et al.Clinical chemistry (Baltimore, Md.). 1996, Vol 42, Num 12, pp 1992-1995, issn 0009-9147Article

Effects of the human apolipoprotein A-I promoter G-A mutation on postprandial lipoprotein metabolismMARIN, Carmen; LOPEZ-MIRANDA, José; GOMEZ, Purificacion et al.The American journal of clinical nutrition. 2002, Vol 76, Num 2, pp 319-325, issn 0002-9165Article

Characterization of monoclonal antibodies against apolipoproteins A-I and A-II. epitope expression in LpA-I and LpA-I:A-II particlesULLOA, N; BUSTOS, P; CASTRO, G et al.Hybridoma. 1999, Vol 18, Num 6, pp 513-520, issn 0272-457XArticle

High density lipoprotein apolipoprotein Al kinetics in NIDDM : a stable isotope studyFRENAIS, R; OUGUERRAM, K; MAUGEAIS, C et al.Diabetologia (Berlin). 1997, Vol 40, Num 5, pp 578-583, issn 0012-186XArticle

Normolipidemic subjects with low HDL cholesterol levels have altered HDL subpopulationsASZTALOS, B. F; LEFEVRE, M; FOSTER, T. A et al.Arteriosclerosis, thrombosis, and vascular biology. 1997, Vol 17, Num 10, pp 1885-1893, issn 1079-5642Article

In vivo metabolism of apo A-I and apo A-II in subjects with apo A-I(Lys₁₀₇→0) associated with reduced HDL cholesterol and Lp(AI w AII) deficiencyTILLY-KIESI, M; PACKARD, C. J; KAHRI, J et al.Atherosclerosis. 1997, Vol 128, Num 2, pp 213-222, issn 0021-9150Conference Paper

Apolipoprotein AI in elderly, thin, non-insulin-dependent diabetic patients and control subjectsFOLIN, M; CONTIERO, E; FERRARI, R et al.Diabetes research. 1995, Vol 29, Num 1, pp 33-44, issn 0265-5985Article

Coronary artery disease in patients at low risk: apolipoprotein AI as an independent risk factorFRANCIS, Michelle C; FROHLICH, Jiri J.Atherosclerosis. 2001, Vol 155, Num 1, pp 165-170, issn 0021-9150Article

High-density lipoproteins from human alcoholics exhibit impaired reverse cholesterol transport functionRAO, Manjunath N; LIU, Qing-Hong; MARMILLOT, Philippe et al.Metabolism, clinical and experimental. 2000, Vol 49, Num 11, pp 1406-1410, issn 0026-0495Article

In vivo kinetics of human apolipoprotein A-I variants in rabbitsSAKU, K; VON ECKARDSTEIN, A; ZHANG, B et al.European journal of clinical investigation. 1999, Vol 29, Num 3, pp 196-203, issn 0014-2972Article

In vivo evidence for increased apolipoprotein A-I catabolism in subjects with impaired glucose tolerancePIETZSCH, J; JULIUS, U; NITZSCHE, S et al.Diabetes (New York, NY). 1998, Vol 47, Num 12, pp 1928-1934, issn 0012-1797Article

Association of alcohol consumption with HDL subpopulations defined by apolipoprotein A-I and apolipoprotein A-II contentBRANCHI, A; ROVELLINI, A; TOMELLA, C et al.European journal of clinical nutrition. 1997, Vol 51, Num 6, pp 362-365, issn 0954-3007Article